Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Nitya Ray Net Worth & Insider Trades

Nitya Ray - Executive Vice President, Actinium Pharmaceuticals, Inc

As of August 4, 2017

What is Nitya Ray's Net Worth?

The current estimated net worth of Actinium Pharmaceuticals, Inc's Executive Vice President, Nitya Ray, is estimated to be about $130.8K . Nitya Ray owns about 10,000 units of Actinium Pharmaceuticals, Inc common stock. Recently at Actinium Pharmaceuticals, Inc, Nitya Ray has sold an estimated value of $0 worth.

What is Nitya Ray's Past Insider Trading?

Nitya Ray's largest purchase order was 10,000 units , worth over $7.5K on August 4, 2017. In total, Nitya Ray has made about 1 transaction recently at Actinium Pharmaceuticals, Inc. Nitya Ray usually trades in August, with the busiest year in 2017.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nitya G Ray

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Nitya Ray's' Mailing Address?

  • Mailing address is 14 Baybury Court East Hanover NJ 07936 NJ

What are Actinium Pharmaceuticals, Inc's Past Insider Trades?

Actinium Pharmaceuticals, Inc's most recent insider trade came on December 10, 2018 by Sandesh Seth who bought 10,000 units worth $4.37K . In the last 5 years, insiders at Actinium Pharmaceuticals, Inc have sold an estimated value of $2.28M and bought an estimated value of $315.67K worth of shares. Insider trading is most common in July, with the busiest year in 2016. The most active traders at the company are Sandesh Seth, Chief Executive Officer,  Memorial Sloan-Kettering Cancer Center,  and Richard Steinhart, Director .

Actinium Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...